Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akorn and Bioniche Pharma have entered into a five-year commercial manufacturing and supply agreement for two pharmaceutical products.
Subscribe to our email newsletter
Under the terms of the five-year agreement, Akorn will be responsible for the manufacturing and supply of the two injectable products. Expected launch for both products is anticipated in the second half of 2008.
Arthur Przybyl, president and CEO of Akorn, said: “We are very pleased to have been selected as the contract manufacturer for these important hospital injectable products. We continue to seek contract pharmaceutical manufacturing opportunities in hospital injectables, ophthalmics and lyophilized products in order to expand this business.”